Healing of Mucocutaneous Lesions With Apremilast in Behçet Disease

J Clin Rheumatol. 2020 Aug;26(5):e132. doi: 10.1097/RHU.0000000000001005.

Authors

Patricia Moya¹, Ivan Castellví¹, Berta Magallares¹, Milena Millan¹, Nicholas Wilson², Hector Corominas¹

Affiliations

¹ From the Division of Rheumatology and Autoimmune Diseases, Hospital Universitari de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
² Bristol Medical School, University of Bristol, Bristol, United Kingdom.

PMID: 30896462
DOI: 10.1097/RHU.0000000000001005

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Behcet Syndrome* / diagnosis
Behcet Syndrome* / drug therapy
Humans
Thalidomide / analogs & derivatives

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast